| domain | neurolign.com |
| summary | NeuroAI has received FDA Breakthrough Designation, which will expedite the approval process for its technology. Their recent research, published in *Experimental Brain Research*, titled “Oculomotor, Vestibular, Reaction Time, and Cognitive OVRT-C Responses in 7- to 17-Year-Old Children,” demonstrates the technology’s value in objectively analyzing eye-tracking, balance, reaction time, and cognition, with applications in pediatric brain health, concussion recovery, and cognitive development. |
| title | Neurolign |
| description | Neurolign |
| keywords | research, technology, tracking, data, more, time, menu, platform, concussion, check, diagnostics, real, detection, objective, main, chair, breakthrough |
| upstreams |
|
| downstreams |
linkedin.com |
| nslookup | A 3.33.251.168, A 15.197.225.128 |
| created | 2024-02-24 |
| updated | 2026-01-27 |
| summarized | 2026-01-31 |
|
|